Revenio Group Corporation: Notice pursuant to chapter 9, section 5 of the securities market act
Revenio Group Corporation, Stock Exchange Release, March 22, 2018 at 9.30
Notice pursuant to chapter 9, section 5 of the securities market act
Revenio Group Corporation has March 21, 2018 received a notification of change in holdings in accordance with Chapter 9, Section 5 of the Securities Markets Act that Joensuun Kauppa ja Kone Oy's share of the total number of shares and voting rights in Revenio Group Corporation has decreased to less than five per cent.
Joensuun Kauppa ja Kone Oy now holds 1.056.600 shares in Revenio Group Corporation, which is 4.41 per cent of the company's shares and voting rights.
The total number of Revenio Group Corporation's shares recorded in the trade register is 23.938.218
Revenio Group Corporation
Timo Hildén
President and CEO
For further information, please contact:
CEO & President Timo Hildén
Telephone: +358 40 580 4774
timo.hilden@revenio.fi
www.revenio.fi
www.ventica.fi
DISTRIBUTION:
Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
The Revenio Group in brief
Revenio is a Finnish, globally operating health technology corporation whose worldwide success is based on a strongly patented intraocular pressure measurement technology. The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The focus of Revenio's screening technology is on the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process.
In 2017, Revenio Group's net sales totaled EUR 26.8 million, with its operating margin, excluding non-recurring items, standing at 35.5%. Revenio Group Corporation is listed on Nasdaq Helsinki.